식물 기반 백신 시장 조사 – 규모, 점유율, 개발 및 미래 범위 2031

  • Report Code : TIPRE00024327
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 243
Buy Now

[연구보고서]식물성 백신 시장은 2021년 11억 4,372만 달러에서 2028년 26억 7,205만 달러에 달할 것으로 예상됩니다. 시장은 2021년부터 2028년까지 연평균 12.9% 성장할 것으로 예상됩니다.



h3>

식물 기반 백신 시장의 범위에는 백신 유형, 소스, 응용 프로그램 및 지역이 포함됩니다. 지역을 기준으로 식물 기반 백신 시장은 북미, 유럽, 아시아 태평양, 중동 및 아프리카, 중남미로 분류됩니다. 이 보고서는 식물 기반 백신 시장에 대한 통찰력과 심층 분석을 제공하며 시장 동향 및 기회, 시장 역학, 북미, 유럽, 아시아 태평양, 중동 및 아프리카, 중남미. 또한 지역에 걸친 COVID-19 영향 분석도 포함됩니다.



전략적 통찰력



식물 기반 백신 시장의 수익성 있는 지역



시장 통찰력



< h3>식물 기반 백신에 대한 연구 개발(R&D) 활동의 증가

치명적인 질병을 예방할 수 있는 백신의 부족으로 인해 문제가 발생했으며 전 세계적으로 보다 안전하고 간편하며 더 많은 백신 개발에 집중하게 되었습니다. 효과적인 백신. 식물은 세계에서 가장 많은 양의 단백질 생성자 중 하나입니다. 식물은 다양한 복잡성과 글리코실화 패턴의 단백질을 효율적으로 발현합니다. 재조합 기술은 필요한 항원 단백질을 암호화하는 유전자가 식물 게놈에 통합되는 식물 유래 백신을 만드는 데 사용됩니다. 더욱이 전문가들은 식물성 백신의 생산에는 백신 제조사들이 계란에 백신을 준비하는 데 걸리는 5~6개월이 아닌 5~6주가 소요될 것으로 추정하고 있다. 전 세계 많은 국가에서 COVID-19의 확산을 막기 위한 효과적인 백신을 개발하고 있으며 식물 기반 백신은 백신 개발을 위한 옵션 중 하나입니다. 식물 기반 백신은 잘 알려진 성공적인 제조 절차와 저렴한 비용으로 인해 연구자들 사이에서 좋은 평판을 얻고 있습니다. 식물성 백신 개발을 위해 다양한 연구와 임상시험을 진행하고 있습니다. 예를 들어, 새로운 백신과 항체를 개발하고 생산하기 위해 식물 기반 기술을 사용하는 임상 단계 생명공학 회사인 Medicago Inc.는 SARS-CoV- 2 유전자(COVID-19 질병을 유발하는 바이러스). 식물 기반 백신 시장의 기존 저명한 플레이어와 신규 참가자는 다양한 치료 응용 분야를 위한 식물 기반 백신을 생산하기 위해 포괄적인 임상 시험을 수행하는 데 노력을 집중하고 있습니다. 따라서 식물 기반 백신에 대한 연구 개발(R&D) 활동의 증가는 전 세계적으로 식물 기반 백신에 대한 수요를 크게 증가시켜 시장 성장을 촉진할 것입니다.



백신 유형 기반 통찰력



백신 유형에 따라 식물 기반 백신 시장은 박테리아 백신, 바이러스 백신, 기생충 백신, 식물 유래 바이러스 유사 입자(VLPS) 등으로 분류됩니다. 박테리아 백신 부문은 2021년 시장에서 가장 큰 점유율을 차지했습니다. 그러나 식물 유래 바이러스 유사 입자(VLP) 부문은 예측 기간 동안 시장에서 13.6%의 가장 높은 CAGR을 기록할 것으로 예상됩니다.



백신 유형별 식물 기반 백신 시장 - 2021년 및 2028년



소스 기반 통찰력



소스를 기반으로 식물 기반 백신 시장은 담배 식물, 옥수수, 감자 등. 담배 플랜트 부문은 2021년에 시장에서 가장 큰 점유율을 차지했으며 동일한 부문이 예측 기간 동안 시장에서 가장 높은 CAGR 13.3%를 기록할 것으로 예상됩니다.



애플리케이션 기반 인사이트

응용 프로그램을 기반으로 식물 기반 백신 시장은 인플루엔자, 지카 바이러스, 에볼라 바이러스, 가금류 질병, COVID-19 등으로 분류됩니다. 인플루엔자 세그먼트는 2021년에 시장에서 가장 큰 점유율을 차지했습니다. 그러나 COVID-19 세그먼트는 예측 기간 동안 시장에서 가장 높은 CAGR 13.8%를 기록할 것으로 예상됩니다.



기업은 일반적으로 무기 전략을 채택합니다. 변화하는 고객 수요에 부응하고 전 세계적으로 브랜드 이름을 유지하기 위한 인수 합병과 같은 식물 기반 백신 시장에서 활동하는 시장 참여자들은 제품 출시 및 확장과 같은 유기적 전략을 채택하여 전 세계적으로 그들의 발자국과 제품 포트폴리오를 확장하고 증가하는 수요를 충족합니다.



백신 유형별



  • 박테리아 백신

  • 바이러스 백신

  • 기생충 백신

  • 식물 유래 바이러스 유사 입자(VLP)

  • 기타< /li>

출처별





  • 담배 공장

  • 옥수수

  • 감자

  • 기타

응용 프로그램별





  • 인플루엔자

  • 지카 바이러스

  • 에볼라 바이러스

  • COVID-19

  • 가금류 질병

  • 기타


지역별





  • 북미

    • US< /li>
    • 캐나다

    • 멕시코



  • 유럽

    • 영국

    • 독일

    • 프랑스

    • 이탈리아

    • 스페인

    • 기타 유럽



  • 아시아 태평양

    • 중국

    • 일본

    • 인도

    • 호주

    • 대한민국

    • 기타 아시아 태평양

    • li>


  • 중동 및 아프리카

    • 사우디아라비아

    • 남아프리카공화국

    • UAE

    • 나머지 중동 및 아프리카



  • 중남미

    • 브라질

    • 아르헨티나

    • 남미 및 중남미 중앙 아메리카




회사 프로필





  • MEDICAGO, INC.

  • British American Tobacco plc
  • ICON GENETICS GMBH

  • CREATIVE BIOLABS, INC.

  • iBio, Inc.

  • LENIOBIO

  • Lumen Bioscience, Inc. .

  • LEAF EXPRESSION SYSTEMS LTD.

  • ZYUS LIFE SCIENCES INC.

  • FRAUNHOFER CMB


Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which source is expected to dominate the market in the forecast period in Plant-Based Vaccines market?

The market is led by source tobacco plant segment is growing significantly due to the increasing use of tobacco plants in pharmaceuticals. The growing research in pharmaceutical is playing a vital role in developing new vaccines. For instance the U.S Department of Agriculture approved a plant-based vaccine for Newcastle disease that infected poultry and produced it in suspension-cultured tobacco cells.

What will be the CAGR of Plant-Based Vaccines market?

The market is estimated to grow with a CAGR of 12.9% from 2021 to 2028.

What are the driving factors for the Plant-based Vaccines market across the globe?

Key factors that are driving growth of the market are increasing number of research & development (R&D) activities in plant-based vaccines and growing prevalence of infectious diseases market fuel the growth of the market.

What are Plant-Based Vaccines?

Plant-based vaccines can be made cheaply and produced on a large scale. These vaccines have several advantages, including being readily accepted by patients and stable for long-term antigen storage. These also help to reduce the economic burden of infectious disease globally. Various plants have developed plant-derived vaccines such as potato, rice, maize, tomato, carrot, tobacco, soybean, and peanut. The choice of the plant depends on the route of administration of the vaccine.

The List of Companies - Plant-based Vaccines Market

  1. MEDICAGO, INC.
  2. British American Tobacco p.l.c.          
  3. ICON GENETICS GMBH
  4. CREATIVE BIOLABS, INC.      
  5. iBio, Inc.
  6. LENIOBIO
  7. Lumen Bioscience, Inc.
  8. LEAF EXPRESSION SYSTEMS LTD.
  9. ZYUS LIFE SCIENCES INC.
  10. FRAUNHOFER CMB

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports